Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by jopatcloon Apr 16, 2024 9:46am
63 Views
Post# 35991288

RE:Hugh MacNaught replied to Osborne Financial Search’s

RE:Hugh MacNaught replied to Osborne Financial Search’s
Fake GranhamWalk the vulture look it's 4 days old. your fear messages don't work
FUDSTER on ceo and here we know your aganda with your many fake accounts here and on ceo and of course your few even follower sheep manipulator. watch out for this manipulator who wants your Shares...
How are user feedback influencing future iterations, Hugh MacNaught?
 
We are bringing greater discipline to the process of ensuring optimal product/market fit. Current actions include working more closely with our distribution partners, visiting existing customer sites, and interacting with cardiology thought leaders. The marketing function is expanding to encompass the entire product life cycle, beginning with identifying unmet medical need and defining product development based on addressing those needs. Ventripoint is conducting workshops at the AEPC meeting in May during which clinicians will have the opportunity to use the system and provide feedback to our clinical applications team. Insights based on user feedback are key to future development!
 

<< Previous
Bullboard Posts
Next >>